These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10208986)

  • 1. Does formyl-methionyl-leucyl-phenylalanine exert a physiological role in labor in women?
    Buzzi M; Vesce F; Ferretti ME; Fabbri E; Biondi C
    Biol Reprod; 1999 May; 60(5):1211-6. PubMed ID: 10208986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formyl-methionyl-leucyl-phenylalanine induces prostaglandin E2 release from human amnion-derived WISH cells by phospholipase C-mediated [Ca+]i rise.
    Biondi C; Pavan B; Ferretti ME; Corradini FG; Neri LM; Vesce F
    Biol Reprod; 2001 Mar; 64(3):865-70. PubMed ID: 11207202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the presence of N-formyl-methionyl-leucyl-phenylalanine (fMLP) receptor ligands in human amniotic fluid and fMLP receptor modulation by physiological labour.
    Biondi C; Pavan B; Dalpiaz A; Valerio A; Spisani S; Vesce F
    J Reprod Immunol; 2005 Dec; 68(1-2):71-83. PubMed ID: 16236365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rebamipide suppresses formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.
    Nagano C; Azuma A; Ishiyama H; Sekiguchi K; Imagawa K; Kikuchi M
    J Pharmacol Exp Ther; 2001 Apr; 297(1):388-94. PubMed ID: 11259567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
    Kew RR; Grimaldi CM; Furie MB; Fleit HB
    J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High constitutive activity of the human formyl peptide receptor.
    Wenzel-Seifert K; Hurt CM; Seifert R
    J Biol Chem; 1998 Sep; 273(37):24181-9. PubMed ID: 9727041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-formyl-methionyl-leucyl-phenylalanine induced accumulation of inositol phosphates indicates the presence of oligopeptide chemoattractant receptors on circulating human lymphocytes.
    Schubert T; Müller WE
    FEBS Lett; 1989 Oct; 257(1):174-6. PubMed ID: 2553489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin H is a potent and selective formyl peptide receptor antagonist. Comparison with N-t-butoxycarbonyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L- leucyl-L-phenylalanine and cyclosporins A, B, C, D, and E.
    Wenzel-Seifert K; Seifert R
    J Immunol; 1993 May; 150(10):4591-9. PubMed ID: 8387097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of a derivative of wheat germ agglutinin which specifically inhibits polymorphonuclear leukocyte chemotaxis to the synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
    Perez HD; Elfman F; Chenoweth D; Hooper C
    J Immunol; 1986 Mar; 136(5):1813-9. PubMed ID: 3753994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
    Goldman DW; Enkel H; Gifford LA; Chenoweth DE; Rosenbaum JT
    J Immunol; 1986 Sep; 137(6):1971-6. PubMed ID: 3018083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A derivative of wheat germ agglutinin specifically inhibits formyl-peptide-induced polymorphonuclear leukocyte chemotaxis by blocking re-expression (or recycling) of receptors.
    Perez HD; Elfman F; Lobo E; Sklar L; Chenoweth D; Hooper C
    J Immunol; 1986 Mar; 136(5):1803-12. PubMed ID: 3753993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular localization and translocation of the receptor for N-formylmethionyl-leucyl-phenylalanine in human neutrophils.
    Sengeløv H; Boulay F; Kjeldsen L; Borregaard N
    Biochem J; 1994 Apr; 299 ( Pt 2)(Pt 2):473-9. PubMed ID: 8172608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of N-formyl-methionyl-leucyl-phenylalanine (fMLP) binding to isolated human neutrophils.
    Psychoyos S; Smith CW
    Agents Actions; 1989 Mar; 26(3-4):372-7. PubMed ID: 2735228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoxin A4 receptor activation is distinct from that of the formyl peptide receptor in myeloid cells: inhibition of CD11/18 expression by lipoxin A4-lipoxin A4 receptor interaction.
    Fiore S; Serhan CN
    Biochemistry; 1995 Dec; 34(51):16678-86. PubMed ID: 8527441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal subepithelial binding sites for the bacterial chemotactic peptide, formyl-methionyl-leucyl-phenylalanine (FMLP).
    Anton P; O'Connell J; O'Connell D; Whitaker L; O'Sullivan GC; Collins JK; Shanahan F
    Gut; 1998 Mar; 42(3):374-9. PubMed ID: 9577344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation.
    McCoy R; Haviland DL; Molmenti EP; Ziambaras T; Wetsel RA; Perlmutter DH
    J Exp Med; 1995 Jul; 182(1):207-17. PubMed ID: 7540650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taxol inhibits N-formyl-methionyl-leucyl-phenylalanine (FMLP)-induced human neutrophil polarization and H2O2 production while decreasing [3H]FMLP binding.
    Iannone MA; Wolberg G; Reynolds-Vaughn R; Zimmerman TP
    Agents Actions; 1987 Aug; 21(3-4):278-80. PubMed ID: 2891263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of leukotrienes by human monocytes pretreated with cytochalasin B and stimulated with formyl-methionyl-leucyl-phenylalanine.
    Williams JD; Robin JL; Lewis RA; Lee TH; Austen KF
    J Immunol; 1986 Jan; 136(2):642-8. PubMed ID: 3001181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic AMP-elevating agents negatively regulate the activation of p72syk in N-formyl-methionyl-leucyl-phenylalanine receptor signaling.
    Asahi M; Tanaka Y; Qin S; Tsubokawa M; Sada K; Minami Y; Yamamura H
    Biochem Biophys Res Commun; 1995 Jul; 212(3):887-93. PubMed ID: 7626126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocytes from chronic myeloid leukemia (CML) patients show differential response to different chemoattractants.
    Radhika V; Thennarasu S; Naik NR; Kumar A; Advani SH; Bhisey AN
    Am J Hematol; 1996 Jul; 52(3):155-64. PubMed ID: 8756080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.